Association for Japan Health Food Certified
JHFC
← Back to Resources

Deep-Sea Fish Oil (EPA/DHA): Testing Standards and Analytical Methods

---

Abstract

Deep-sea fish oil is one of the best-selling categories of dietary nutritional supplements worldwide. Its core value lies in its richness in two long-chain omega-3 polyunsaturated fatty acids (LC-PUFAs): eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). However, the natural-origin nature of fish oil means there is considerable variability in raw material quality, content uniformity, oxidative stability, and contaminant load. This paper focuses on the dimensions of testing standards and analytical methods, systematically reviewing the methodological principles behind key testing parameters — including EPA/DHA content determination, purity and oxidation indicators, heavy metals, and microbiological testing — and, drawing on both and international regulatory frameworks, provides practical guidance for interpreting test reports. The aim is to serve as an objective reference for industry practitioners and quality-conscious consumers.

---

I. Regulatory Frameworks and Major Standards Systems

1.1 Japan's Domestic Regulatory Framework

Japan's regulation of health foods is grounded in the Food Sanitation Act and the Health Promotion Act. The Foods with Function Claims system, which came into effect in 2015, requires businesses to submit substantiation of safety and functionality to the Consumer Affairs Agency prior to market launch, including a mandatory obligation to quantitatively declare EPA/DHA content. For products claiming to contain EPA/DHA, content labeling must be based on actual measured data; declaration based solely on theoretical formulation values is not permitted. The GMP Conformance Certification System of the Japan Health and Nutrition Food Association (JHNFA) sets explicit requirements for testing frequency and methods at each stage of the production process, and certified facilities are subject to periodic third-party audits.

1.2 Major International Reference Standards

Standard / OrganizationKey DocumentCore Focus
GOED (Global Organization for EPA and DHA Omega-3s)GOED Voluntary Monograph (latest edition)EPA+DHA content, oxidation indicators, contaminant limits
IFOS (International Fish Oil Standards)IFOS Five-Star Rating SystemComprehensive quality scoring, including oxidation, contaminants, and EPA/DHA label claim compliance
Codex AlimentariusCXS 329-2017 (Fish Oils Standard)Fatty acid composition, contaminants, physicochemical parameters
CRN / AHPAIndustry self-regulatory guidelinesSupplementary reference for the US market
ISO / AOACMultiple analytical method standardsCertification of specific determination methods

It is worth noting that these standards are complementary rather than mutually exclusive. High-quality products typically undergo self-testing or third-party testing against multiple sets of standards simultaneously.

---

II. Methods for Determining EPA/DHA Content

2.1 Gas Chromatography (GC) — The Industry's Primary Method

Gas chromatography (GC) combined with a flame ionization detector (FID) is the current gold-standard method for the quantitative analysis of EPA and DHA. It is adopted in multiple international standards, including AOAC Official Method 991.39, EN 14103, and ISO 5508/5509.

Methodological Principle:

The triglycerides (TG) or free fatty acids (FFA) in the sample are first saponified (alkaline hydrolysis) and then subjected to transesterification with methanol under acid or base catalysis, converting the fatty acids into fatty acid methyl esters (FAMEs). The FAME mixture is injected into the GC system, where the components are separated on the stationary phase according to differences in carbon chain length and degree of unsaturation. Each component sequentially reaches the FID to generate a signal, and the mass fraction of each fatty acid is calculated against reference standards using either the internal standard method or the external standard method.

Key Technical Considerations:

Expression of Results:

EPA/DHA content is commonly expressed in two forms: "milligrams per 100 grams (or per gram) of total fatty acids," which reflects the concentration in the raw material, or "milligrams per daily serving," which is the most intuitive labeling format for consumers.

2.2 High-Performance Liquid Chromatography (HPLC)

HPLC — particularly reverse-phase HPLC with ultraviolet detection (UV 210 nm) — can be used for fatty acid analysis in fish oil, but offers lower resolution for PUFAs than GC. It finds greater application in the qualitative and quantitative analysis of phospholipid-bound EPA/DHA in phospholipid-form omega-3 products (such as krill oil), as well as in the screening of lipid-soluble impurities.

2.3 Nuclear Magnetic Resonance (NMR)

¹H-NMR and ³¹P-NMR techniques enable rapid, non-destructive characterization of the overall fatty acid composition and glyceride structure (sn-position distribution) in fish oil. However, their quantitative precision and throughput are not yet on par with GC-FID. At present, NMR is used primarily for structural identification and adulteration screening research, and has not been widely incorporated into routine quality control workflows.

---

III. Testing for Purity and Oxidation Indicators

The highly unsaturated nature of polyunsaturated fatty acids makes them highly susceptible to lipid peroxidation. Oxidative degradation not only causes loss of active constituents, but the secondary oxidation products generated (aldehydes, ketones) may also affect product safety. Accordingly, oxidation indicators are among the most critical dimensions of fish oil quality assessment.

3.1 Peroxide Value (PV)

Method: Iodometric titration (ISO 3960) or iron/thiocyanate-based spectrophotometry.

Principle: PV measures the content of primary oxidation products — hydroperoxides (ROOH) — expressed in meq/kg or mEq/kg.

Reference Limits: The GOED Monograph requires PV ≤ 5 meq/kg for finished fish oil products; Codex CXS 329-2017 sets PV ≤ 10 meq/kg for refined fish oils. An elevated PV indicates oxidation is still at an early stage; however, hydroperoxides are themselves unstable and will continue to decompose during storage, which limits the value of PV as a standalone assessment.

3.2 p-Anisidine Value (p-AV)

Method: ISO 6885; p-methoxybenzaldehyde is used as a chromogenic reagent. It reacts with aldehydes in acetic acid solution, and absorbance is read at 350 nm.

Principle: p-AV measures secondary oxidation products, principally α,β-unsaturated aldehydes (such as 2-alkenals and 2,4-dienals), which are the primary source of fishy and rancid off-odors. GOED requires p-AV ≤ 20.

3.3 TOTOX Value (Total Oxidation Value)

TOTOX = 2×PV + p-AV, providing a comprehensive assessment of both primary and secondary degrees of oxidation. GOED requires TOTOX ≤ 26. TOTOX is currently the single composite oxidation indicator most widely cited in the industry. Its advantage lies in overcoming the misleading effect of PV declining in the mid-to-late stages of oxidation as hydroperoxides decompose — a decline that could otherwise give a false impression of improvement.

3.4 Acid Value (AV) and Free Fatty Acids (FFA)

Method: ISO 660, potassium hydroxide titration.

AV reflects the proportion of free fatty acids generated by the hydrolysis of glycerides. GOED requires AV ≤ 3 mg KOH/g (equivalent to FFA ≤ 1.5%). An elevated AV is generally associated with insufficient freshness of the raw fish material or deficiencies in the refining process.

3.5 EPA/DHA Formulation Type and Stability Considerations

The main fish oil formulation types on the market are natural triglyceride (TG), ethyl ester (EE), and re-esterified triglyceride (rTG). The ethyl ester form requires hydrolysis by pancreatic lipase in vivo before absorption and is comparatively less stable at elevated temperatures; the triglyceride form exhibits slightly superior stability under natural conditions. Test reports should specify the formulation type to allow evaluation against the relevant reference values.

---

IV. Testing for Heavy Metals and Environmental Contaminants

4.1 Mercury and Methylmercury

Mercury — and in particular organic mercury (methylmercury), which possesses greater neurotoxicity — is the primary contaminant of concern for deep-sea fish products. Large predatory fish (tuna, swordfish) accumulate higher levels of mercury due to biomagnification; the small pelagic species primarily used as fish oil raw materials — sardines, anchovies, mackerel — have comparatively lower mercury levels, though testing is still required.

Analytical Methods:

Reference Limit: GOED requires total mercury ≤ 0.1 mg/kg (100 μg/kg).

4.2 Lead, Cadmium, and Arsenic

Analytical Methods: ICP-MS or graphite furnace atomic absorption spectrometry (GFAAS); samples are prepared by microwave digestion (wet method) or dry ashing prior to analysis.

Reference Limits (GOED Monograph):

ElementUpper Limit (mg/kg)
Lead (Pb)0.1
Cadmium (Cd)0.1
Arsenic (As, inorganic)0.1

It is important to note that arsenic is naturally present in marine organisms predominantly in organic forms (arsenobetaine and others), which have far lower toxicity than inorganic arsenic. If a test report specifies only "total arsenic" rather than "inorganic arsenic," the result must be interpreted with this background knowledge in mind. A high-quality report should distinguish between inorganic and organic arsenic.

4.3 Persistent Organic Pollutants (POPs)

Dioxins and Polychlorinated Biphenyls (PCBs): While not routine testing items for all products, international quality benchmarks (GOED) require their testing. Analysis is typically performed using high-resolution gas chromatography–mass spectrometry (HRGC/HRMS), with reference to regulatory limits such as EU Regulation EC 1881/2006.

Polycyclic Aromatic Hydrocarbons (PAHs): Where activated carbon is used in the refining process for decolorization, it must be confirmed that the total PAH4 content (benzo[a]pyrene, benzo[a]anthracene, benzo[b]fluoranthene, and chrysene) complies with EU regulatory requirements (≤ 10 μg/kg).

---

V. Microbiological Testing

Fish oil is a lipid-soluble product with an extremely low water activity (Aw), which means the risk of microbial proliferation is relatively low. However, the gelatin shell and filling excipients of soft gelatin capsule formulations, as well as the manufacturing environment, may introduce microbiological contamination, making routine microbiological control testing necessary.

Primary Testing Parameters:

Test ParameterMethod ReferenceTypical Limit
Total Plate Count (TPC)ISO 4833≤ 1,000 CFU/g
ColiformsISO 4832Not detected (below 10 CFU/g)
Yeasts and MoldsISO 21527≤ 100 CFU/g
*Staphylococcus aureus*ISO 6888Not detected
*Salmonella* spp.ISO 6579Not detected (per 25 g sample)

For softgel products, the capsule shell and fill content must be evaluated separately. The cleanroom classification of the filling environment (typically Grade D or above) also affects the final microbiological burden.

---

VI. Guide to Interpreting Test Reports

6.1 Checking for Essential Report Elements

A credible third-party test report should include: the credentials of the issuing laboratory (ISO/IEC 17025 accreditation mark, such as JCSS in Japan, A2LA, etc.), sample number and traceability information, the reference number of the analytical method standard used, a comparison of measured values against reference values, a statement of measurement uncertainty, and the signature of an authorized signatory.

6.2 Assessing Deviation Between Measured and Labeled EPA/DHA Values

6.3 Comprehensive Interpretation of Oxidation Indicators

No single oxidation indicator should be evaluated in isolation. It is recommended to review all three parameters together (PV, p-AV, and TOTOX):

6.4 Contextualizing Heavy Metal Results

When reading heavy metal results against GOED or applicable regulatory limits, attention must be paid to unit conversion (μg/kg = ppb; mg/kg = ppm) to avoid misreading values that differ by a factor of 1,000. For arsenic results, it must be confirmed whether the figure represents an inorganic arsenic–specific determination or merely total arsenic.

---

VII. Actionable Guidance for Consumers

The following are quality dimensions that consumers can independently verify through publicly available information when selecting deep-sea fish oil products:

---

Conclusion

The quality assessment of deep-sea fish oil is a multidimensional, systematic undertaking. The accurate labeling of EPA/DHA content is merely the entry-level criterion; oxidative status, contaminant levels, microbiological control, and batch-to-batch consistency together constitute the complete picture of product quality. From an analytical methodology standpoint, GC-FID remains the core tool for EPA/DHA quantification; TOTOX, as a composite oxidation indicator, has become the common language of industry communication; and ICP-MS provides an efficient means of simultaneous multi-element testing for heavy metals.

For industry practitioners, establishing a full-chain testing system covering incoming raw material inspection, in-process control, and finished product release — and commissioning reports from laboratories holding ISO/IEC 17025 accreditation — is the foundational work underpinning label claim compliance and consumer trust. For consumers, understanding the basic structure of test reports and the key indicators involved supports more rational decision-making based on the dimension of informational transparency. The ongoing evolution of regulatory requirements and the increasing openness of third-party rating systems are jointly driving the industry toward higher testing standards and greater levels of disclosure.

---

*The testing methods and reference limits described in this document are derived from publicly available international standards and industry guidelines. They are provided for informational purposes only and do not constitute medical advice or product recommendations. Dietary nutritional supplements are not a substitute for a balanced diet. Any decisions regarding intake should be made in consultation with a qualified healthcare professional.*

This document concerns quality/transparency only and makes no claim of pharmaceutical efficacy or disease treatment/prevention.
← Back to Resources